Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7688615rdf:typepubmed:Citationlld:pubmed
pubmed-article:7688615lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:7688615lifeskim:mentionsumls-concept:C0023828lld:lifeskim
pubmed-article:7688615lifeskim:mentionsumls-concept:C2003941lld:lifeskim
pubmed-article:7688615lifeskim:mentionsumls-concept:C0376315lld:lifeskim
pubmed-article:7688615lifeskim:mentionsumls-concept:C1292724lld:lifeskim
pubmed-article:7688615pubmed:issue2lld:pubmed
pubmed-article:7688615pubmed:dateCreated1993-9-16lld:pubmed
pubmed-article:7688615pubmed:abstractTextThe authors have obtained several variants of liposomal forms of human alpha 2-interferon. The forms intended to preserve antiviral activity with regard to the methods of liposomal formation were comparatively studied. It has been found that liposomal formation through stirring caused no decrease in antiviral activity.lld:pubmed
pubmed-article:7688615pubmed:languageruslld:pubmed
pubmed-article:7688615pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7688615pubmed:citationSubsetIMlld:pubmed
pubmed-article:7688615pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7688615pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7688615pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7688615pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7688615pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7688615pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7688615pubmed:statusMEDLINElld:pubmed
pubmed-article:7688615pubmed:issn0869-6047lld:pubmed
pubmed-article:7688615pubmed:authorpubmed-author:TorchilinV...lld:pubmed
pubmed-article:7688615pubmed:authorpubmed-author:VardanianN...lld:pubmed
pubmed-article:7688615pubmed:authorpubmed-author:PopovV FVFlld:pubmed
pubmed-article:7688615pubmed:authorpubmed-author:ZolinV VVVlld:pubmed
pubmed-article:7688615pubmed:authorpubmed-author:Kolokol'tsovA...lld:pubmed
pubmed-article:7688615pubmed:authorpubmed-author:Luk'ianovA...lld:pubmed
pubmed-article:7688615pubmed:authorpubmed-author:NesterovA EAElld:pubmed
pubmed-article:7688615pubmed:authorpubmed-author:AntonovN ANAlld:pubmed
pubmed-article:7688615pubmed:issnTypePrintlld:pubmed
pubmed-article:7688615pubmed:ownerNLMlld:pubmed
pubmed-article:7688615pubmed:authorsCompleteYlld:pubmed
pubmed-article:7688615pubmed:pagination29-31lld:pubmed
pubmed-article:7688615pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:7688615pubmed:meshHeadingpubmed-meshheading:7688615-...lld:pubmed
pubmed-article:7688615pubmed:meshHeadingpubmed-meshheading:7688615-...lld:pubmed
pubmed-article:7688615pubmed:meshHeadingpubmed-meshheading:7688615-...lld:pubmed
pubmed-article:7688615pubmed:meshHeadingpubmed-meshheading:7688615-...lld:pubmed
pubmed-article:7688615pubmed:meshHeadingpubmed-meshheading:7688615-...lld:pubmed
pubmed-article:7688615pubmed:meshHeadingpubmed-meshheading:7688615-...lld:pubmed
pubmed-article:7688615pubmed:meshHeadingpubmed-meshheading:7688615-...lld:pubmed
pubmed-article:7688615pubmed:meshHeadingpubmed-meshheading:7688615-...lld:pubmed
pubmed-article:7688615pubmed:meshHeadingpubmed-meshheading:7688615-...lld:pubmed
pubmed-article:7688615pubmed:year1993lld:pubmed
pubmed-article:7688615pubmed:articleTitle[Methodological approaches to creating a liposomal form of human recombinant alpha 2-interferon].lld:pubmed
pubmed-article:7688615pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7688615pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:7688615pubmed:publicationTypeEnglish Abstractlld:pubmed